stockrowNautilus Biotechnology, Inc. (NAUT) vs Prelude Therapeutics Incorporated (PRLD)
- Nautilus Biotechnology, Inc. NAUT 2.23 +3.72%
- Prelude Therapeutics Incorporated PRLD 3.60 +1.12%
Nautilus Biotechnology, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Nautilus Biotechnology, Inc. and Prelude Therapeutics Incorporated are of similar size ($283.7M and $273.9M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −269.8%) and the lower return on invested capital (−133.5% vs 0.00%). Across the 13 metrics below, Nautilus Biotechnology, Inc. leads on 7 and Prelude Therapeutics Incorporated on 6.
Valuation
Profitability
| Metric | NAUT | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | (300.56%) | 0.00% |
| Net margin | 0.00% | (269.75%) | 0.00% |
| Free cash flow margin | 0.00% | (148.30%) | 0.00% |
| Return on equity | (41.01%) | (57.73%) | (51.96%) |
| Return on assets | (33.49%) | (39.76%) | (46.06%) |
| Return on invested capital | (133.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack